Insider trade

Director reported a gift or transfer of 800 VRTX shares

Traded Nov 19, 2025 · Filed Nov 20, 2025

Vertex PharmaceuticalsVRTX

800
Shares

Why it stands out

Gift or transfer — classified separately from trades.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Nov 19, 2025
Reporting period: Not applicable
Filed with the SEC: Nov 20, 2025

DirectorGift / transfer

Context

Classification

gift transfer

Code G — gift, bequest or transfer

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000875320-25-000238
Filed / recorded

Nov 20, 2025, 9:03 PM UTC

Added to OQRO

Oct 2, 2026, 12:29 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

VERTEX PHARMACEUTICALS INC / MA

Issuer CIK

875320

Ticker

VRTX

Reporting person

Lloyd Carney

Relationship

Director

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Nov 19, 2025

Transaction code

G

Shares / units

800

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

6,315

Ownership form

Direct

Amendment

No

Around the same time

Officer sold ~$3.16M of Vertex Pharmaceuticals

Scheduled in advance10mo ago

Officer sold ~$3.23M of Vertex Pharmaceuticals

Scheduled in advance10mo ago

Officer sold ~$2.02M of Vertex Pharmaceuticals

Scheduled in advance10mo ago